Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, Share, Opportunities & Competitive Analysis, 2024 – 2032
Neuromyelitis Optica Spectrum Disorder (NMOSD) Market size was valued USD 2341 million in 2024 and is anticipated to reach USD 4397.91 million by 2032, at a CAGR of 8.2% during the forecast period. Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare, chronic autoimmune disease of the central nervous system characterized by severe inflammation of the optic nerves and spinal cord. Once frequently misdiagnosed as multiple sclerosis, NMOSD is now recognized as a distinct clinical entity with unique biomarkers, disease progression patterns, and therapeutic requirements. This growing clinical clarity, combined with rapid therapeutic innovation, is reshaping the global NMOSD market and driving sustained interest from pharmaceutical companies, clinicians, and healthcare systems. Browse the full report at: https://www.credenceresearch.com/report/neuromyelitis-optica-spectrum-disorder-nmosd-market Understanding NMOSD and Its Clinical Burden NMOSD primarily affects ...